NEW YORK (GenomeWeb News) – Investigators at the Georgia Regents University have netted a $10 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to continue pursuing a long-term, international effort to study the genetic and environmental contributors to type 1 diabetes, the university said today.

The NIDDK grant to Jin-Xiong She, director of the Medical College of Georgia's Center for Biotechnology and Genomic Medicine, will support the next phases of The Environmental Determinants of Diabetes in the Young study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.